Palleon Pharmaceuticals lands $100m Series B
Palleon Pharmaceuticals, a biotech company, has closed $100 million in Series B financing.
Palleon Pharmaceuticals, a biotech company, has closed $100 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination